IL2RA and acute myeloid leukemia: Within the CBF AML subgroup, IL2RA mRNA expression status was significantly associated with age (p = 0.026) and FLT3-ITD (p = 0.023) status (Table 4), but not with c-KIT D816V mutation (p = 1.000, Table 4).